These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6243256)

  • 1. Prostaglandin E2 rather than lymphocyte-activating factor produced by activated human mononuclear cells stimulates increases in murine thymocyte cAMP.
    Oppenheim JJ; Koopman WJ; Wahl LM; Dougherty SF
    Cell Immunol; 1980 Jan; 49(1):64-73. PubMed ID: 6243256
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanisms of action of "lymphocyte activating factor" (LAF)--II. LAF effect is resistant to elevation of cellular cyclic AMP.
    Kierszenbaum F; Waksman BH
    Immunochemistry; 1978 Nov; 15(10-11):807-11. PubMed ID: 218885
    [No Abstract]   [Full Text] [Related]  

  • 3. Regulation of thymocyte proliferative response by macrophage-derived prostaglandin E2 and interleukin 1.
    Hayari Y; Kukulansky T; Globerson A
    Eur J Immunol; 1985 Jan; 15(1):43-7. PubMed ID: 2981690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitogenic activity of Actinomyces viscosus. I. Effects on murine B and T lymphocytes, and partial characterization.
    Engel D; Clagett J; Page R; Williams B
    J Immunol; 1977 Apr; 118(4):1466-71. PubMed ID: 66295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defective Fc-mediated phagocytosis in C3H/HeJ macrophages. II. Correction by cAMP agonists.
    Vogel SN; Weedon LL; Oppenheim JJ; Rosenstreich DL
    J Immunol; 1981 Feb; 126(2):441-5. PubMed ID: 6256439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective tumoricidal capacity of macrophages from P/J mice: tumoricidal defect involves abnormalities in lymphokine-derived activation stimuli and in mononuclear phagocyte responsiveness.
    Boraschi D; Meltzer MS
    J Immunol; 1980 Aug; 125(2):777-82. PubMed ID: 6993563
    [No Abstract]   [Full Text] [Related]  

  • 7. Partial characterization of a prostaglandin-induced suppressor factor.
    Rogers TJ; Nowowiejski I; Webb DR
    Cell Immunol; 1980 Mar; 50(1):82-93. PubMed ID: 6967359
    [No Abstract]   [Full Text] [Related]  

  • 8. Interactions between 8-L-arginine vasopressin and prostaglandin E2 in human mononuclear phagocytes.
    Locher R; Vetter W; Block LH
    J Clin Invest; 1983 Apr; 71(4):884-91. PubMed ID: 6300191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The adenosine 3':5'-cyclic monophosphate response to prostaglandin E2 is altered in U937 cells in association with maturational events induced by activated T lymphocytes and 1,25-dihydroxyvitamin D3.
    Goldring SR; Amento EP; Roelke MS; Krane SM
    J Immunol; 1986 May; 136(9):3461-6. PubMed ID: 2420890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin E1 treatment of NZB/W mice. III. Preservation of spleen cell concentrations and mitogen-induced proliferative responses.
    Krakauer KA; Torrey SB; Zurier RB
    Clin Immunol Immunopathol; 1978 Nov; 11(3):256-66. PubMed ID: 309371
    [No Abstract]   [Full Text] [Related]  

  • 11. The effects of indomethacin on T lymphocyte stimulation.
    Kingston AE; Ivanyi J; Kay JE
    Immunol Lett; 1984; 8(6):301-5. PubMed ID: 6335488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of prostaglandin on the antigen- and mitogen-driven responses of peripheral blood lymphocytes from patients with adult and juvenile periodontitis.
    Page RC; Clagett JA; Engel LD; Wilde G; Sims T
    Clin Immunol Immunopathol; 1978 Sep; 11(1):77-87. PubMed ID: 699390
    [No Abstract]   [Full Text] [Related]  

  • 13. Prostaglandin-mediated suppression of macrophage phagocytosis of Listeria monocytogenes.
    Hutchison DL; Myers RL
    Cell Immunol; 1987 Nov; 110(1):68-76. PubMed ID: 3119229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of cell cycle to recovery of IL 2 activity from human mononuclear cells, human and mouse T cell lines.
    Stadler BM; Dougherty SF; Farrar JJ; Oppenheim JJ
    J Immunol; 1981 Nov; 127(5):1936-40. PubMed ID: 6975304
    [No Abstract]   [Full Text] [Related]  

  • 15. One third of murine splenic T cells are cytotoxic precursors induced to grow by leucoagglutinin and TCGF.
    Larsson EL
    Scand J Immunol; 1981 May; 15(5):515-9. PubMed ID: 6980449
    [No Abstract]   [Full Text] [Related]  

  • 16. Biologic properties of chromatographically separated murine thymoma-derived Interleukin 2 and colony-stimulating factor.
    Hilfiker ML; Moore RN; Farrar JJ
    J Immunol; 1981 Nov; 127(5):1983-7. PubMed ID: 6170682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphokine maintains macrophage activation for tumor cell killing by interfering with the negative regulatory effect of prostaglandin E2.
    Taffet SM; Pace JL; Russell SW
    J Immunol; 1981 Jul; 127(1):121-4. PubMed ID: 6263971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Release of the lymphokine osteoclast activating factor requires cyclic AMP accumulation.
    Yoneda T; Mundy GR
    Calcif Tissue Int; 1982 Mar; 34(2):204-8. PubMed ID: 6177386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal cell (keratinocyte)-derived thymocyte-activating factor (ETAF).
    Luger TA; Stadler BM; Katz SI; Oppenheim JJ
    J Immunol; 1981 Oct; 127(4):1493-8. PubMed ID: 6974195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin regulation of macrophage function: effect of endogenous and exogenous prostaglandins.
    Snider ME; Fertel RH; Zwilling BS
    Cell Immunol; 1982 Dec; 74(2):234-42. PubMed ID: 6962757
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.